Citation Information :
Ramamurthy J. Prevalence of Oral Mucosal Lesions in Patients with Type II Diabetes Mellitus: A Retrospective Analysis. World J Dent 2023; 14 (8):683-687.
Aim: The aim of the study was to identify the prevalence of oral mucosal lesions in patients with type II diabetes mellitus (DM).
Materials and methods: The present study was a retrospective study which was conducted among patients visiting the outpatient department of a private hospital in Chennai. Patients who were diagnosed with type II DM and presented with no other additional systemic illness who reported to the hospital from June 2019 to March 2020 were included in the study. Oral mucosal alterations were recorded. The collected data was imported into the Statistical Package for the Social Sciences (SPSS) software by International Business Machines (IBM) and analyzed by descriptive analysis and Pearson correlation.
Results: The prevalence of oral lesions among the study population of 200 patients with type II DM was 26 (13%). The presence of oral lesions was the most (7%) among the middle-aged population (36–60 years). The male population (52%) showed more prevalence of oral lesions, compared to the females (48%). The most common oral lesion among the study population was lichen planus (32%), followed by angular cheilitis (24%), denture stomatitis (20%), leukoplakia (8%), geographic tongue (8%), and oral candidiasis (8%).
Conclusion: Patients with type II DM present with an increased risk of manifestation of oral lesions. The middle-aged population (30–60 years) are at a higher risk of developing oral mucosal lesions, compared to the other age-groups. The most common oral lesion associated with this age-group was lichen planus (30%) and also it was found that males were at higher risk of development of oral mucosal lesions.
Clinical significance: Diabetes mellitus (DM) type II is characterized by impaired immune function resulting in various oral lesions. DM causes oral complications which are considered to be major complications of the disease and can decrease the patient's quality of life. Hence, early diagnosis helps in the prevention of complications.
Vasconcelos BC, Novaes M, Sandrini FA, et al. Prevalence of oral mucosa lesions in diabetic patients: a preliminary study. Braz J Otorhinolaryngol 2008;74(3):423–428. DOI: 10.1016/s1808-8694(15)30578-4
Tommasi AF, Tommasi MH. Diagnóstico em Patologia Bucal. Elsevier Brasil; 2015.
Cicmil A, Govedarica O, Lečić J, et al. Oral symptoms and mucosal lesions in patients with diabetes mellitus type 2. Balkan J Dent Med 2017;21(1):50–54. DOI: 10.1515/bjdm-2017-0007
Bastos AS, Leite AR, Spin-Neto R, et al. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract 2011;92(1):100–105. DOI: 10.1016/j.diabres.2011.01.011
Albert DA, Ward A, Allweiss P, et al. Diabetes and oral disease: implications for health professionals. Ann N Y Acad Sci 2012;1255:1-15. DOI: 10.1111/j.1749-6632.2011.06460.x
Al-Maskari AY, Al-Maskari MY, Al-Sudairy S, et al. Oral manifestations and complications of diabetes mellitus: a review. Sultan Qaboos Univ Med J 2011;11(2):179–186. PMID: 21969888.
Taboza ZA, Costa KL, Silveira VR, et al. Periodontitis, edentulism and glycemic control in patients with type 2 diabetes: a cross-sectional study. BMJ Open Diabetes Res Care 2018;6(1):e000453. DOI: 10.1136/bmjdrc-2017-000453
Ramamurthy J, Nd J, Varghese S. Comparison of salivary beta glucuronidase activity in chronic periodontitis patients with and without diabetes mellitus. J Clin Diagn Res 2014;8(6):ZC19–ZC21. DOI: 10.7860/JCDR/2014/8713.4476
Deepika BA, Ramamurthy J. Role of triggered receptor expressed in myeloid cells (TREM) in periodontal disease: a systematic review. J Pop Therapeutic Clin Pharmacol 2023;30(10):125–146. DOI: 10.47750/jptcp.2023.30.10.018
Steele JC, Clark HJ, Hong CH, et al. World workshop on oral medicine VI: an international validation study of clinical competencies for advanced training in oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120(2):143–151.e7. DOI: 10.1016/j.oooo.2014.12.026
Jahanbani J, Sandvik L, Lyberg T, et al. Evaluation of oral mucosal lesions in 598 referred Iranian patients. Open Dent J 2009;3:42–47. DOI: 10.2174/1874210600903010042
Guggenheimer J, Moore PA, Rossie K, et al. Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II. Prevalence and characteristics of Candida and Candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89(5):570–576. DOI: 10.1067/moe.2000.104477
Trentin MS, Verardi G, De C Ferreira M, et al. Most frequent oral lesions in patients with type 2 diabetes mellitus. J Contemp Dent Pract 2017;18(2):107–111. DOI: 10.5005/jp-journals-10024-1999
Manfredi M, McCullough MJ, Vescovi P, et al. Update on diabetes mellitus and related oral diseases. Oral Dis 2004;10(4):187–200. DOI: 10.1111/j.1601-0825.2004.01019.x
Mauri-Obradors E, Estrugo-Devesa A, Jané-Salas E, et al. Oral manifestations of diabetes mellitus. A systematic review. Med Oral Patol Oral Cir Bucal 2017;22(5):e586–e594. DOI: 10.4317/medoral.21655
Bartholomew GA, Rodu B, Bell DS. Oral candidiasis in patients with diabetes mellitus: a thorough analysis. Diabetes Care 1987;10(5):607–612. DOI: 10.2337/diacare.10.5.607
Rodrigues C, Rodrigues M, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med 2019;8(1):76. DOI: 10.3390/jcm8010076
López-López J, Jané-Salas E, Estrugo-Devesa A, et al. Periapical and endodontic status of type 2 diabetic patients in Catalonia, Spain: a cross-sectional study. J Endod 2011;37(5):598–601. DOI: 10.1016/j.joen.2011.01.002
Indurkar MS, Maurya AS, Indurkar S. Oral manifestations of diabetes. Clin Diabetes 2016;34(1):54–57. DOI: 10.2337/diaclin.34.1.54